NVO Jun 2024 80.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:08AM EDT. Market open.
| Previous close | 4.0900 |
| Open | 4.0900 |
| Bid | 3.7000 |
| Ask | 4.0000 |
| Strike | 80.00 |
| Expiry date | 2024-06-21 |
| Day's range | 4.0900 - 4.0900 |
| Contract range | N/A |
| Volume | |
| Open interest | 452 |
Zacks3 Stocks to Focus on as Demand for Obesity Drugs Booms
With the obesity market gaining popularity, analysts are expecting sales to increase. Pharma companies are rushing to enter the market
Motley FoolIs Novo Nordisk a Good Passive Income Stock?
Passive income investors know that when there's a business that's proven to throw off a lot of cash consistently over time, it might be a good idea to hold its shares to capture safe and reliable dividends for the long haul. Novo Nordisk (NYSE: NVO) is an obvious candidate to consider right now. Thanks to its blockbuster drug Ozempic and a pipeline that's chock-full of other potential winners, Novo Nordisk seems to have most of the makings of a great dividend stock.
Yahoo FinanceAmazon Health: A long play and a search for partners
Amazon Pharmacy is just one of the segments of health that the e-retail giant is pursuing.
© 2023 Yahoo. All rights reserved.
